EDDP is the primary metabolite your body produces when it breaks down methadone. When it appears on a drug test, it confirms that someone actually ingested and processed methadone rather than simply adding the drug to a urine sample. The standard screening cutoff for EDDP in urine is 100 ng/mL.
What EDDP Actually Is
EDDP stands for 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine. It’s an inactive substance, meaning it has no drug effects on its own. After you take methadone, your liver breaks it down through a process called N-demethylation, primarily using a liver enzyme called CYP3A4. The intermediate product of that breakdown is another compound called normethadone, but it dehydrates so rapidly that it’s nearly impossible to detect. EDDP is what remains and accumulates in urine, making it the most reliable marker that methadone was actually consumed and metabolized.
Why Labs Test for EDDP Instead of Just Methadone
Testing for methadone alone has a significant blind spot: someone could add methadone directly to a urine sample without ever swallowing it. This is a concern in substance abuse treatment programs, where patients receive methadone under strict dosing regimens and are monitored for compliance. If a person diverts their dose (selling or giving it away) but wants to appear compliant, they could spike their urine sample with unmetabolized methadone.
EDDP solves this problem. Because it’s only produced inside the body through liver metabolism, its presence in urine is strong evidence the person actually took the medication. Clinics often look at both methadone and EDDP levels together. A sample that contains methadone but no EDDP raises a red flag for possible tampering, though research from Norwegian prison populations found that methadone-positive, EDDP-negative results don’t always indicate fraud. Some individuals simply metabolize the drug differently.
Providers also use the ratio of EDDP to creatinine (a natural waste product in urine) to build a more complete picture of whether a patient is taking their medication consistently and at the prescribed dose.
How Long EDDP Stays Detectable
EDDP typically becomes detectable in urine within 15 to 55 hours after a dose of methadone and can remain detectable for up to 7 days. That window varies based on how quickly your liver processes methadone, your hydration level, kidney function, and whether you take other medications that speed up or slow down liver enzymes. People on long-term, stable methadone doses tend to have more consistent EDDP levels than someone who took a single dose.
What Your Results Mean
A positive EDDP result means methadone was ingested and metabolized. In a treatment setting, this is the expected finding for a compliant patient. If you’re not prescribed methadone and your test comes back positive for EDDP, it indicates methadone exposure.
When both methadone and EDDP are present, the ratio between them can tell clinicians something about how your body handles the drug. A relatively high amount of methadone compared to EDDP could suggest recent dosing (the liver hasn’t finished processing it yet), slower-than-average metabolism, or in some cases, that extra methadone was added to the sample. A high EDDP level relative to methadone generally reflects normal or fast metabolism and is consistent with someone who took their dose on schedule.
Individual variation matters here. Genetic differences in liver enzymes, age, body weight, and other medications all affect how quickly methadone converts to EDDP. Two people on the same dose can produce noticeably different ratios.
False Positives on Methadone and EDDP Screens
Standard urine drug screens use a method called enzyme immunoassay, which works by detecting substances that bind to a specific antibody. The problem is that some medications have a similar enough chemical shape to trigger a positive result even when methadone was never taken. Medications documented to cause false positives on methadone-specific immunoassay screens include verapamil (a blood pressure drug), quetiapine (an antipsychotic), diphenhydramine (the active ingredient in Benadryl), and doxylamine (a sleep aid found in NyQuil).
If a screening result seems inconsistent with what you know about your medication history, confirmatory testing using a more precise method like gas chromatography-mass spectrometry can distinguish EDDP from look-alike compounds. This confirmatory step is standard practice before any clinical or legal decisions are made based on a positive screen.
Where You’ll See EDDP Testing
EDDP testing is most common in three settings: opioid treatment programs that prescribe methadone for addiction, chronic pain clinics that use methadone for pain management, and workplace or legal drug screens that include a methadone panel. Not every standard drug test includes EDDP. Basic five-panel and ten-panel screens often test for methadone itself but may not specifically look for the metabolite. Extended panels and compliance-focused testing in treatment programs are where EDDP screening is routine.
If your drug test paperwork lists “methadone metabolite” or “EDDP,” it’s specifically looking for evidence that methadone was processed by the body, not just present in the sample.